Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| RADIANT LOGI | RLGT | 4.26% |
| GREENLIGHT C | GLRE | 2.73% |
| SUMMER INFAN | SUMR | 2.41% |
| META FINANCI | CASH | 2.39% |
| OLD SECOND B | OSBC | 1.85% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Roper Industries Inc. ( ROP - Snapshot Report ) recently completed the acquisition of privately-held Sunquest Information Systems Inc. for approximately $1.415 billion, including $25.0 million in cash tax benefits. Roper used its available cash and credit facility to fund the acquisition.
Tucson, Arizona-based Sunquest develops software solutions for clinical and anatomic laboratory professionals. Its solutions are used to improve workflow automation and integrate important data that forms the backbone of diagnostics decision making. Sunquest has a strong clientele of more than 1,700 hospitals worldwide.
Roper plans to integrate Sunquest in the Medical & Scientific Imaging segment. Sunquest is expected to contribute approximately $75.0 million in revenue through the rest of 2012. The acquisition is expected to generate significant cash flow, which prompted Roper to raise its operating cash flow guidance to $700.0 million for fiscal 2012 (up from $650.0 to $675.0 million). Roper expects the acquisition to generate EBITDA of approximately $140.0 million or more in 2013.
Over the years, acquisitions have been an integral part of Roper’s growth story. To date in fiscal 2012, Sunquest is Roper’s fourth acquisition. Roper acquired Shanghai Hao Ying Measurement & Control Technology Co, Ltd. (January), Cambridge Viscosity, Inc. (February) and Ascension Technology Corp. (May) this year.
The recent acquisitions reflect Roper’s focus on expanding its high-margin businesses. Given Sunquest’s significant growth opportunities, recurring revenue stream and strong cash flow generation, we believe that the acquisition will be accretive for Roper over the long term.
Roper recently announced its second quarter 2012 results. Total revenue increased 3.5% year over year to $724.9 million, with acquisitions contributing 3.0% to revenue growth, while 3.0% came from organic growth. For further details please see Roper Posts EPS In line, Revs Miss.
We believe that Roper will continue to pursue acquisitions based on its strong balance sheet and solid cash flows. At the end of the second quarter, Roper’s cash and cash equivalents were $518.9 million. Along with the new $1.5 billion credit facility, it looks to be well-equipped to buy companies with significant growth opportunities in the near term.
We believe that strong backlog coupled with robust organic growth will drive earnings growth going forward. Moreover, accretive acquisitions will expand its product portfolio, providing a significant competitive edge over peers such as Agilent Technologies Inc. ( A - Analyst Report ) and Halliburton Company ( HAL - Analyst Report ) over the long term.
We maintain an Outperform recommendation over the long term (6-12 months). Currently, Roper has a Zacks #1 Rank, which implies a short-term Strong Buy rating on the stock.
Read the full reports :
Snapshot Report on ROP
Analyst Report on A
Analyst Report on HAL